Report #2860076

Overview

Sex

Female

Age

Age unknown

State

NJ

Recovered

Recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

she developed had low grade fever (never going above 100 degrees); This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (she developed had low grade fever (never going above 100 degrees)) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Crohn's disease. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PYREXIA (she developed had low grade fever (never going above 100 degrees)). At the time of the report, PYREXIA (she developed had low grade fever (never going above 100 degrees)) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low grade fever. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use), the reporter did not provide any causality assessments. The concomitant medication was not reported by the reporter. About one or two years ago, the patient received a COVID-19 vaccine (believed to be a Moderna product). She developed a low-grade fever (that never went above 100 degrees). The fever lasted intermittently for about two weeks. She had no other symptoms, did not feel ill, and after two weeks, the fever disappeared. She experienced no further problems. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.

Current illness

Crohn's disease

Lab data

Test Name: fever; Result Unstructured Data: low grade fever